Middle Meningeal Artery Embolization for Patients With Chronic Subdural Hematoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Middle Meningeal Artery Embolization for Patients With Chronic Subdural Hematoma — Stella

Recruiting

Back to Endovascular Treatment trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Japan

Hyogo Medical University, Nishinomiya, Hyōgo

Key details

Sponsor

Kazutaka Uchida

Enrollment target

~600 participants

Started

December 2024

Primary completion

August 2027

Age range

18 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov